Titre : Lactoyl glutathione lyase

Lactoyl glutathione lyase : Questions médicales fréquentes

Termes MeSH sélectionnés :

Data Accuracy
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Lactoyl glutathione lyase : Questions médicales les plus fréquentes", "headline": "Lactoyl glutathione lyase : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Lactoyl glutathione lyase : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-19", "dateModified": "2025-02-13", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Lactoyl glutathione lyase" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Carbon-sulfur lyases", "url": "https://questionsmedicales.fr/mesh/D013437", "about": { "@type": "MedicalCondition", "name": "Carbon-sulfur lyases", "code": { "@type": "MedicalCode", "code": "D013437", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.520.300" } } }, "about": { "@type": "MedicalCondition", "name": "Lactoyl glutathione lyase", "alternateName": "Lactoylglutathione Lyase", "code": { "@type": "MedicalCode", "code": "D007791", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Yu-Zhong Zhang", "url": "https://questionsmedicales.fr/author/Yu-Zhong%20Zhang", "affiliation": { "@type": "Organization", "name": "College of Marine Life Sciences, Frontiers Science Center for Deep Ocean Multispheres and Earth System, Ocean University of China, Qingdao 266003, China." } }, { "@type": "Person", "name": "Julie D Saba", "url": "https://questionsmedicales.fr/author/Julie%20D%20Saba", "affiliation": { "@type": "Organization", "name": "Children's Hospital Oakland Research Institute, University of California, San Francisco Benioff Children's Hospital Oakland, Oakland, CA 94609 jsaba@chori.org." } }, { "@type": "Person", "name": "Lidia de Bari", "url": "https://questionsmedicales.fr/author/Lidia%20de%20Bari", "affiliation": { "@type": "Organization", "name": "Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies-CNR, Via G. Amendola 122/O, 70126 Bari, Italy." } }, { "@type": "Person", "name": "Marissa N Trujillo", "url": "https://questionsmedicales.fr/author/Marissa%20N%20Trujillo", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Erin Q Jennings", "url": "https://questionsmedicales.fr/author/Erin%20Q%20Jennings", "affiliation": { "@type": "Organization", "name": "" } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Optimizing data integration in trials that use EHR data: lessons learned from a multi-center randomized clinical trial.", "datePublished": "2023-09-01", "url": "https://questionsmedicales.fr/article/37658391", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13063-023-07563-y" } }, { "@type": "ScholarlyArticle", "name": "Initiatives, Concepts, and Implementation Practices of the Findable, Accessible, Interoperable, and Reusable Data Principles in Health Data Stewardship: Scoping Review.", "datePublished": "2023-08-28", "url": "https://questionsmedicales.fr/article/37639292", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2196/45013" } }, { "@type": "ScholarlyArticle", "name": "Equity and bias in electronic health records data.", "datePublished": "2023-05-22", "url": "https://questionsmedicales.fr/article/37225122", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.cct.2023.107238" } }, { "@type": "ScholarlyArticle", "name": "Data quality and autism: Issues and potential impacts.", "datePublished": "2022-11-28", "url": "https://questionsmedicales.fr/article/36455477", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ijmedinf.2022.104938" } }, { "@type": "ScholarlyArticle", "name": "The Detection of Date Shifting in Real-World Data.", "datePublished": "2023-07-17", "url": "https://questionsmedicales.fr/article/37459888", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1055/a-2130-2197" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Enzymes et coenzymes", "item": "https://questionsmedicales.fr/mesh/D045762" }, { "@type": "ListItem", "position": 3, "name": "Enzymes", "item": "https://questionsmedicales.fr/mesh/D004798" }, { "@type": "ListItem", "position": 4, "name": "Lyases", "item": "https://questionsmedicales.fr/mesh/D008190" }, { "@type": "ListItem", "position": 5, "name": "Carbon-sulfur lyases", "item": "https://questionsmedicales.fr/mesh/D013437" }, { "@type": "ListItem", "position": 6, "name": "Lactoyl glutathione lyase", "item": "https://questionsmedicales.fr/mesh/D007791" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Lactoyl glutathione lyase - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Lactoyl glutathione lyase", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-04", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Lactoyl glutathione lyase", "description": "Comment diagnostiquer une déficience en lactoyl glutathione lyase ?\nQuels tests sont utilisés pour évaluer l'activité de cette enzyme ?\nQuels symptômes peuvent indiquer un problème avec cette enzyme ?\nY a-t-il des biomarqueurs associés à cette enzyme ?\nPeut-on utiliser l'imagerie pour diagnostiquer des troubles liés à cette enzyme ?", "url": "https://questionsmedicales.fr/mesh/D007791?mesh_terms=Data+Accuracy&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Lactoyl glutathione lyase", "description": "Quels sont les symptômes d'une déficience en lactoyl glutathione lyase ?\nLa déficience peut-elle causer des problèmes cutanés ?\nY a-t-il des symptômes digestifs associés ?\nLes symptômes varient-ils selon l'âge ?\nPeut-on observer des symptômes psychologiques ?", "url": "https://questionsmedicales.fr/mesh/D007791?mesh_terms=Data+Accuracy&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Lactoyl glutathione lyase", "description": "Comment prévenir les complications liées à cette enzyme ?\nY a-t-il des tests de dépistage recommandés ?\nLes antioxydants peuvent-ils prévenir des problèmes ?\nEst-il important de gérer le stress ?\nLes vaccinations sont-elles importantes ?", "url": "https://questionsmedicales.fr/mesh/D007791?mesh_terms=Data+Accuracy&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Lactoyl glutathione lyase", "description": "Quels traitements sont disponibles pour la déficience en lactoyl glutathione lyase ?\nLa thérapie génique est-elle une option ?\nDes changements alimentaires peuvent-ils aider ?\nY a-t-il des médicaments spécifiques à éviter ?\nLes traitements sont-ils personnalisés ?", "url": "https://questionsmedicales.fr/mesh/D007791?mesh_terms=Data+Accuracy&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Lactoyl glutathione lyase", "description": "Quelles complications peuvent survenir avec cette déficience ?\nLa déficience peut-elle affecter le système immunitaire ?\nY a-t-il des risques de maladies chroniques ?\nLes complications sont-elles réversibles ?\nComment surveiller les complications potentielles ?", "url": "https://questionsmedicales.fr/mesh/D007791?mesh_terms=Data+Accuracy&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Lactoyl glutathione lyase", "description": "Quels sont les facteurs de risque pour cette déficience ?\nL'âge joue-t-il un rôle dans le risque ?\nY a-t-il des maladies associées à ce risque ?\nLe mode de vie influence-t-il le risque ?\nLes facteurs environnementaux sont-ils significatifs ?", "url": "https://questionsmedicales.fr/mesh/D007791?mesh_terms=Data+Accuracy&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une déficience en lactoyl glutathione lyase ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests enzymatiques et des analyses génétiques peuvent confirmer la déficience." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'activité de cette enzyme ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests biochimiques mesurant l'activité enzymatique dans des échantillons biologiques." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un problème avec cette enzyme ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes de stress oxydatif, comme la fatigue ou des troubles neurologiques." } }, { "@type": "Question", "name": "Y a-t-il des biomarqueurs associés à cette enzyme ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des niveaux anormaux de glutathion et de lactate peuvent être des biomarqueurs." } }, { "@type": "Question", "name": "Peut-on utiliser l'imagerie pour diagnostiquer des troubles liés à cette enzyme ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'imagerie n'est pas spécifique, mais peut aider à évaluer des complications associées." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une déficience en lactoyl glutathione lyase ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, troubles neurologiques, et susceptibilité accrue aux infections." } }, { "@type": "Question", "name": "La déficience peut-elle causer des problèmes cutanés ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des éruptions cutanées et une sensibilité accrue peuvent survenir." } }, { "@type": "Question", "name": "Y a-t-il des symptômes digestifs associés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles digestifs comme des nausées peuvent être présents." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent être plus prononcés chez les jeunes enfants." } }, { "@type": "Question", "name": "Peut-on observer des symptômes psychologiques ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles de l'humeur et de l'anxiété peuvent être liés à cette déficience." } }, { "@type": "Question", "name": "Comment prévenir les complications liées à cette enzyme ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain et une alimentation équilibrée peuvent aider à prévenir les complications." } }, { "@type": "Question", "name": "Y a-t-il des tests de dépistage recommandés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de dépistage génétique peuvent être recommandés pour les familles à risque." } }, { "@type": "Question", "name": "Les antioxydants peuvent-ils prévenir des problèmes ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une consommation adéquate d'antioxydants peut réduire le stress oxydatif." } }, { "@type": "Question", "name": "Est-il important de gérer le stress ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la gestion du stress est cruciale pour maintenir une bonne santé cellulaire." } }, { "@type": "Question", "name": "Les vaccinations sont-elles importantes ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les vaccinations peuvent aider à prévenir les infections chez les personnes à risque." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour la déficience en lactoyl glutathione lyase ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des suppléments de glutathion et des antioxydants peuvent être recommandés." } }, { "@type": "Question", "name": "La thérapie génique est-elle une option ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique est en recherche, mais pas encore largement disponible." } }, { "@type": "Question", "name": "Des changements alimentaires peuvent-ils aider ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en antioxydants peut soutenir la santé cellulaire." } }, { "@type": "Question", "name": "Y a-t-il des médicaments spécifiques à éviter ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments oxydants doivent être évités pour réduire le stress oxydatif." } }, { "@type": "Question", "name": "Les traitements sont-ils personnalisés ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent être adaptés selon la gravité des symptômes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec cette déficience ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des infections récurrentes et des troubles neurologiques peuvent survenir." } }, { "@type": "Question", "name": "La déficience peut-elle affecter le système immunitaire ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut affaiblir le système immunitaire, augmentant le risque d'infections." } }, { "@type": "Question", "name": "Y a-t-il des risques de maladies chroniques ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un stress oxydatif accru peut contribuer à des maladies chroniques." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes." } }, { "@type": "Question", "name": "Comment surveiller les complications potentielles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des suivis réguliers avec des professionnels de santé sont essentiels pour surveiller les complications." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour cette déficience ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des antécédents familiaux et des expositions environnementales peuvent augmenter le risque." } }, { "@type": "Question", "name": "L'âge joue-t-il un rôle dans le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jeunes enfants sont plus susceptibles de présenter des déficiences enzymatiques." } }, { "@type": "Question", "name": "Y a-t-il des maladies associées à ce risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines maladies métaboliques peuvent être liées à un risque accru de déficience." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie malsain peut augmenter le risque de complications liées à cette enzyme." } }, { "@type": "Question", "name": "Les facteurs environnementaux sont-ils significatifs ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des toxines environnementales peut augmenter le risque de déficience." } } ] } ] }

Sources (10000 au total)

Optimizing data integration in trials that use EHR data: lessons learned from a multi-center randomized clinical trial.

Despite great promise, trials that ascertain patient clinical data from electronic health records (EHR), referred to here as "EHR-sourced" trials, are limited by uncertainty about how existing trial s... We describe a demonstration project that used EHR data to complement data collected for a contemporary multi-center pharmaceutical industry outcomes trial, and how a central coordinating center suppor... While broadening the type of sites able to participate in EHR-sourced trials may lead to greater generalizability and improved enrollment, sites with fewer technical resources may require additional s...

Initiatives, Concepts, and Implementation Practices of the Findable, Accessible, Interoperable, and Reusable Data Principles in Health Data Stewardship: Scoping Review.

Thorough data stewardship is a key enabler of comprehensive health research. Processes such as data collection, storage, access, sharing, and analytics require researchers to follow elaborate data man... This scoping review identifies and discusses concepts, approaches, implementation experiences, and lessons learned in FAIR initiatives in health research data.... The Arksey and O'Malley stage-based methodological framework for scoping reviews was applied. PubMed, Web of Science, and Google Scholar were searched to access relevant publications. Articles written... A total of 2.18% (34/1561) of the screened articles were included in the final review. The authors reported FAIRification approaches, which include interpolation, inclusion of comprehensive data dicti... This work summarises projects, tools, and workflows for the FAIRification of health research data. The comprehensive review shows that implementing the FAIR concept in health data stewardship carries ... RR2-10.2196/22505....

Data quality and autism: Issues and potential impacts.

Large healthcare datasets can provide insight that has the potential to improve outcomes for patients. However, it is important to understand the strengths and limitations of such datasets so that the... Data were extracted from the HES database for the period 1st April 2013 to 31st March 2021 for patients with a diagnosis of autism. First spells in hospital during the study period were identified for... Data were available for 172,324 unique patients who had been recorded as having an autism diagnosis on first admission. In total, 43.7 % of subsequent spells were found to have inconsistencies. The fe... Data inconsistencies in the HES database were relatively common in autistic patients and were associated a number of patient and hospital admission characteristics. Such inconsistencies have the poten...

The Detection of Date Shifting in Real-World Data.

Analysis of health care real-world data (RWD) provides an opportunity to observe the actual patient diagnostic, treatment, and outcome events. However, researchers should understand the possible limit... A methodology for detecting the presence of shifted dates in RWD was developed by considering various approaches to confirm the expected occurrences of medical events, including unique temporal occurr... Twenty-eight of the 71 HCOs analyzed were predicted by methodology and confirmed by their data providers to have shifted data. Likewise, 39 were predicted and confirmed to not have shifted data. With ... The presence of date shifting for U.S. HCOs may be reliably detected assessing whether the routine exams should always occur on weekdays....

Assessing the quality of emergency department data for injury surveillance in Victoria, Australia: a comparative analysis of two Victorian hospital data sources.

The emergency department (ED) is pivotal in treating serious injuries, making it a valuable source for population-based injury surveillance. In Victoria, information that is relevant to injury surveil... A retrospective observational study of administrative healthcare data.... VEMD and VAED data from July 2014 to June 2019 were compared. Including only hospitals contributing to both datasets, cases that (1) arrived at the ED and (2) were subsequently admitted, were selected... While the overall number of cases was similar, VAED outnumbered VEMD cases (414 630 vs 404 608), suggesting potential under-reporting of injuries in the ED. Age-related differences indicated a relativ... Injury cases were more numerous in the VAED than in the VEMD even though the number is expected to be equal based on case selection. Older patients were under-represented in the VEMD; this could partl...

Improving the Data Quality of Untargeted Metabolomics through a Targeted Data-Dependent Acquisition Based on an Inclusion List of Differential and Preidentified Ions.

Metabolomics based on high-resolution mass spectrometry has become a powerful technique in biomedical research. The development of various analytical tools and online libraries has promoted the identi...

Consistency as a Data Quality Measure for German Corona Consensus Items Mapped from National Pandemic Cohort Network Data Collections.

As a national effort to better understand the current pandemic, three cohorts collect sociodemographic and clinical data from coronavirus disease 2019 (COVID-19) patients from different target populat... The goal of this work is to assure high consistency of research data mapped to the GECCO data model. In particular, it aims at identifying contradictions within interdependent GECCO data items of the ... All suitable data items from each of the three NAPKON cohorts are mapped to the GECCO items. A consistency assessment tool (dqGecco) is implemented, following the design of an existing quality assessm... Our consistency assessment tool helped in correcting the mapping procedure and reveals remaining contradictory value combinations within COVID-19 symptoms, vital signs, and COVID-19 severity. Consiste... An efficient and portable tool capable of discovering inconsistencies in the COVID-19 domain has been developed and applied to three different cohorts. As the GECCO dataset is employed in different pl...

Routine use of DHIS2 data: a scoping review.

In regard to health service planning and delivery, the use of information at different levels in the health system is vital, ranging from the influencing of policy to the programming of action to the ... The five-stage approach of Arksey and O'Malley progressed by Levac et al. and Peters was followed. Three databases (PubMed, Web of Science and Embase) were searched, along with relevant conference pro... Overall, DHIS2 data are being used but there are few detailed descriptions of this usage in peer reviewed or grey literature. We find that, commonly, there exists a centralised versus decentralised pa... We conclude with some suggestions for a way forward, namely: i) the need to document in more detail and share how data are being used, ii) the need to investigate how data were created and who uses su...